Cisplatin Nephrotoxicity: A Summary of Preventative Interventions
Drug Intelligence & Clinical Pharmacy · 1985-05 · 19 (5) · 362-367
DOI: 10.1177/106002808501900505 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Intelligence & Clinical Pharmacy, online erschienen am 25.10.2017. Verfasst von R S Finley und 2 weiteren Autor:innen. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Nephrotoxicity is usually the dose-limiting toxicity associated with cisplatin therapy. Frequently the nephrotoxicity is mild and reversible. However, it is both dose-related and cumulative and may become life-threatening and irreversible at higher dosages. Many interventions such as vigorous hydration, osmotic or loop diuretics, and alterations of infusion times have been evaluated in the hope of ameliorating this serious toxicity, and are summarized. More recently, hypertonic NaCl 0.9% has been reported to decrease the incidence of cisplatin nephrotoxicity. In addition, newer platinum analogs are currently undergoing clinical trials to ascertain if they retain the antitumor properties of cisplatin but produce less toxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Zitieren
APA
Finley, R. S., Fortner, C. L., & Grove, W. R. (1985). Cisplatin Nephrotoxicity: A Summary of Preventative Interventions. Drug Intelligence & Clinical Pharmacy, 19(5), 362-367. https://doi.org/10.1177/106002808501900505
Vancouver
Finley RS, Fortner CL, Grove WR. Cisplatin Nephrotoxicity: A Summary of Preventative Interventions. Drug Intelligence & Clinical Pharmacy. 1985;19(5):362-367. doi:10.1177/106002808501900505
BibTeX
@article{Finley1985,
author = {Finley, R S and Fortner, C L and Grove, W R},
title = {Cisplatin Nephrotoxicity: A Summary of Preventative Interventions},
journal = {Drug Intelligence & Clinical Pharmacy},
year = {1985},
volume = {19},
number = {5},
pages = {362--367},
doi = {10.1177/106002808501900505}
}
EUVIMED